» Authors » Jakub Wojcieszak

Jakub Wojcieszak

Explore the profile of Jakub Wojcieszak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 313
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wojcieszak J, Kuczynska K, Leszczynska A, Narazinski E, Cichalewska-Studzinska M
Pharmacol Rep . 2025 Feb; PMID: 39903426
No abstract available.
2.
Wojcieszak J, Kuczynska K, Leszczynska A, Narazinski E, Cichalewska-Studzinska M
Pharmacol Rep . 2025 Jan; PMID: 39869285
Background: The current study investigated the effects of high-fat diet on acute response to 3,4-methylenedioxypyrovalerone (MDPV) in mice. MDPV is a beta-cathinone derivative endowed with psychostimulant activity. Similarly to recreational...
3.
Kuczynska K, Bartkowska K, Djavadian R, Zwierzynska E, Wojcieszak J
Pharmacol Rep . 2024 May; 76(3):519-534. PMID: 38722542
Background: Synthetic cathinones (SC) constitute the second most frequently abused class of new psychoactive substances. They serve as an alternative to classic psychostimulatory drugs of abuse, such as methamphetamine, cocaine,...
4.
Wang L, Wojcieszak J, Kumar R, Zhao Z, Sun X, Xie S, et al.
Mol Neurobiol . 2023 Sep; 61(3):1479-1494. PMID: 37726498
FK506-binding protein 51 kDa (FKBP51), encoded by Fkbp5 gene, gained considerable attention as an important regulator of several aspects of human biology including stress response, metabolic dysfunction, inflammation, and age-dependent...
5.
Zawilska J, Adamowicz P, Kurpeta M, Wojcieszak J
Forensic Sci Int . 2023 Jul; 349:111775. PMID: 37423031
Background: New synthetic opioids (NSO) constitute one of the fastest-growing group of New Psychoactive Substances, which emerged on the illicit drug marker in the second half of 2000's. The most...
6.
Kacela M, Wojcieszak J, Zawilska J
Psychiatr Pol . 2022 Aug; 56(2):355-372. PMID: 35988080
Objectives: The study was aimed to analyze information posted by users of synthetic opioids on Polish online drug discussion forums. Special emphasis was given to sources of drugs and their...
7.
Wojcieszak J, Kuczynska K, Zawilska J
J Mol Neurosci . 2022 Jul; 72(9):1929-1951. PMID: 35821178
Alzheimer's disease (AD) is a progressive neurogenerative disorder manifested by gradual memory loss and cognitive decline due to profound damage of cholinergic neurons. The neuropathological hallmarks of AD are intracellular...
8.
Wojcieszak J, Kuczynska K, Zawilska J
Neurotox Res . 2021 Jan; 39(3):575-587. PMID: 33428180
Synthetic cathinones appeared on the market in the 2000s as new psychoactive substances and gained significant prevalence among drug abusers. Cathinones produce psychostimulant and empathogenic effects by enhancing dopaminergic, noradrenergic,...
9.
Wojcieszak J, Kuczynska K, Zawilska J
Neurotox Res . 2020 Jun; 38(2):536-551. PMID: 32506339
Two chloromethcathinones, 3-chloromethcathinone (3-CMC) and 4-chloromethcathinone (4-CMC), and two para-substituted α-pyrrolidinophenones, 4-methoxy-α-pyrrolidinopentiophenone (4-MeO-PVP) and 4-fluoro-α-pyrrolidinopentiophenone (4-F-PVP), represent synthetic cathinones, the second most frequently abused group of new psychoactive substances (NPSs),...
10.
Nekvinda J, Rozycka D, Rykowski S, Wyszko E, Fedoruk-Wyszomirska A, Gurda D, et al.
Bioorg Chem . 2019 Nov; 94:103432. PMID: 31776032
The development of 1,8-naphthalimide derivatives as DNA-targeting anticancer agents is a rapidly growing area and has resulted in several derivatives entering into clinical trials. One of original recent developments is...